ArticleCell death & disease2019

The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs.

Lanyang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.